FIGURE 3-1. Policy issues at the intersection of multiple health care stakeholders' interests.

FIGURE 3-1Policy issues at the intersection of multiple health care stakeholders' interests

From: 3, Supportive Policy Environment for Biomarker Tests for Molecularly Targeted Therapies

Cover of Biomarker Tests for Molecularly Targeted Therapies
Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine.
Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies; Board on Health Care Services; Institute of Medicine; National Academies of Sciences, Engineering, and Medicine; Graig LA, Phillips JK, Moses HL, editors.
Washington (DC): National Academies Press (US); 2016 Jun 30.
Copyright 2016 by the National Academy of Sciences. All rights reserved.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.